ALAMEDA, Calif. & FARMINGTON, Conn.--(BUSINESS WIRE)--AgeX Therapeutics, Inc. (AgeX: NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration, and ImStem Biotechnology, Inc., a biopharmaceutical company developing human embryonic stem cell-derived mesenchymal stem cells (hES-MSC), today announced their signing of a non-binding letter of intent for ImStem to obtain from AgeX a non-exclusive license to use AgeXs embryonic stem cell line ESI 053 to derive ImStems investigational MSC product IMS001 for development in COVID-19 as well as acute respiratory distress syndrome (ARDS) due to other causes. AgeX and ImStem are co-operating to finalize financial terms and other provisions of a license agreement.
ImStem has previously used AgeX ESI 053 to derive the ImStem IMS001 product which is being investigated for multiple sclerosis under an IND. Earlier this year, the U.S. Food and Drug Administration (FDA) cleared IMS001 to begin a Phase 1 clinical study in patients with multiple sclerosis, after a clinical hold on its Investigational New Drug (IND) application was removed. This is believed to be the first MSC product derived from human embryonic stem cells to be accepted for a clinical trial by the FDA. AgeX and ImStem already have a commercial license in place, which grants ImStem rights to use AgeXs ESI 053 to derive IMS001 as a product candidate for development in autoimmune disease, including multiple sclerosis.
To date, in patients with pneumonia and ARDS due to COVID-19, preliminary literature suggests MSCs, such as ImStems hES-MSC candidate IMS001, may warrant further development consideration. An early clinical study conducted in China by an unrelated group with a different MSC product, Transplantation of ACE2- Mesenchymal Stem Cells Improves the Outcome of Patients with COVID-19 Pneumonia, and published in Aging and Disease (2020, Vol. 11, No. 2, pp. 216-228) showed that an intravenous infusion of a different MSC product appeared safe and improved functional outcomes in seven treated patients with COVID-19 pneumonia. MSCs are well recognized to be immunomodulatory in nature, possessing immunosuppressive and anti-inflammatory properties.
Even before their application to COVID-19, MSCs were being investigated as a potential therapeutic option in ARDS, and emerging data in preclinical models has been encouraging. ARDS remains an area of considerable unmet medical need, affecting around 200,000 patients annually in the U.S., accounting for 10% of all intensive care unit patients, and having a mortality of approximately 40%. At the present time, no specific direct therapies exist for ARDS and only supportive treatment is available.
We feel privileged to be part of a global effort to combat COVID-19. This is a unique opportunity for AgeX to leverage its resources to help with the public health challenge at hand. Decades of pioneering work with human embryonic stem cells means this technology is now at a point where it may play a role in the development of a cell-based approach to combating COVID-19. We are very excited by the prospect of expanding our relationship with ImStem to include COVID-19 and ARDS, said Dr. Nafees Malik, Chief Operating Officer of AgeX.
We welcome the opportunity to continue to collaborate with AgeX and explore future development of our IMS001 product in COVID-19 and ARDS from other causes, commented Richard Kim, M.D., Chief Medical Officer of ImStem Biotechnology.
About AgeX Therapeutics
AgeX Therapeutics, Inc. (NYSE American: AGE) is focused on developing and commercializing innovative therapeutics for human aging. AgeXs PureStem and UniverCyte manufacturing and immunotolerance technologies are designed to work together to generate highly defined, universal, allogeneic, off-the-shelf pluripotent stem cell-derived young cells of any type for application in a variety of diseases with a high unmet medical need. AgeX has two preclinical cell therapy programs: AGEX-VASC1 (vascular progenitor cells) for tissue ischemia and AGEX-BAT1 (brown fat cells) for Type II diabetes. AgeXs revolutionary longevity platform induced Tissue Regeneration (iTR) aims to unlock cellular immortality and regenerative capacity to reverse age-related changes within tissues. AGEX-iTR1547 is an iTR-based formulation in preclinical development. HyStem is AgeXs delivery technology to stably engraft PureStem cell therapies in the body. AgeXs core product pipeline is intended to extend human healthspan. AgeX is seeking opportunities to establish licensing and collaboration arrangements around its broad IP estate and proprietary technology platforms and therapy product candidates.
For more information, please visit http://www.agexinc.com or connect with the company on Twitter, LinkedIn, Facebook, and YouTube.
About ImStem Biotechnology
ImStem Biotechnology, Inc. is aspiring to revolutionize how serious diseases with significant unmet needs are treated with a new generation of regenerative and cellular therapies. Pioneering research by its current founder and Chief Technology Officer Dr. Xiaofang Wang and Dr. Ren-He Xu, former director of UConn Stem Cell Institute, led to the proprietary state-of-the-art pluripotent stem cell technology, enabling off-the-shelf, allogeneic stem cell-derived products to be manufactured in scale, differentiating itself from the typical challenges imposed by autologous adult cell therapy products. The company's mission is to advance the science and understanding of human pluripotent stem cell based regenerative cellular therapies through novel and creative development pathways and to fulfill unmet medical needs in serious diseases. And its development strategy focuses on neurologic, autoimmune, degenerative, and rare orphan diseases. ImStem Biotechnology Inc. is a privately held company headquartered in Farmington, CT.
For more information, visit http://www.imstem.com.
Forward-Looking Statements for AgeX
Certain statements contained in this release are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements that are not historical fact including, but not limited to statements that contain words such as will, believes, plans, anticipates, expects, estimates should also be considered forward-looking statements. Forward-looking statements involve risks and uncertainties. Actual results may differ materially from the results anticipated in these forward-looking statements and as such should be evaluated together with the many uncertainties that affect the business of AgeX Therapeutics, Inc. and its subsidiaries, particularly those mentioned in the cautionary statements found in more detail in the Risk Factors section of AgeXs most recent Annual Report on Form 10-K and Quarterly Report on Form 10-Q filed with the Securities and Exchange Commissions (copies of which may be obtained at http://www.sec.gov). Subsequent events and developments may cause these forward-looking statements to change. In addition, with respect to AgeXs letter of intent with ImStem there is no assurance that (i) AgeX and ImStem will successfully conclude negotiations and enter into a license agreement; (ii) ImStem will be successful in developing any therapeutic products from a stem cell line licensed by AgeX or that any therapeutic product that may be developed will receive FDA or foreign regulatory approval, or (iii) AgeX will derive revenue or other financial benefits from any license agreement that might be signed with ImStem. AgeX specifically disclaims any obligation or intention to update or revise these forward-looking statements as a result of changed events or circumstances that occur after the date of this release, except as required by applicable law.
- 001 Stem Cell Therapy: Age of Human Cell Engineering is Born [Last Updated On: June 25th, 2010] [Originally Added On: June 25th, 2010]
- 002 Angel Biotechnology (ABH) - Video [Last Updated On: October 15th, 2011] [Originally Added On: October 15th, 2011]
- 003 Future of Health Care - medical, health and hospital trends - Biotechnology company keynote 2002 by - Video [Last Updated On: November 18th, 2011] [Originally Added On: November 18th, 2011]
- 004 Philippines banks on biotechnology to deal with enviromentally friendly issues, food security considerations [Last Updated On: December 18th, 2011] [Originally Added On: December 18th, 2011]
- 005 Biotechnology: Boon to Human being [Last Updated On: December 18th, 2011] [Originally Added On: December 18th, 2011]
- 006 Growth and development of Biotechnology [Last Updated On: December 18th, 2011] [Originally Added On: December 18th, 2011]
- 007 Biotechnological innovation on Farming Skill [Last Updated On: December 18th, 2011] [Originally Added On: December 18th, 2011]
- 008 Curing the entire world through biotechnology [Last Updated On: December 18th, 2011] [Originally Added On: December 18th, 2011]
- 009 India emerging as a global hub for stem cell research [Last Updated On: January 22nd, 2012] [Originally Added On: January 22nd, 2012]
- 010 Scientists make ethical stem cells from skin of a rat [Last Updated On: January 22nd, 2012] [Originally Added On: January 22nd, 2012]
- 011 South Korea again gives a go ahead to use of human eggs in cloning research [Last Updated On: February 5th, 2012] [Originally Added On: February 5th, 2012]
- 012 Angel Biotechnology - Contracts with Materia Medica [Last Updated On: February 6th, 2012] [Originally Added On: February 6th, 2012]
- 013 Cellerant Therapeutics Appoints Lowell E. Sears to Board of Directors [Last Updated On: February 22nd, 2012] [Originally Added On: February 22nd, 2012]
- 014 Angel Biotechnology - Grant of Share Options [Last Updated On: February 28th, 2012] [Originally Added On: February 28th, 2012]
- 015 RBCC Closes Deal with Game Changing Biotech Firm [Last Updated On: March 15th, 2012] [Originally Added On: March 15th, 2012]
- 016 Biotechnology Screencast Session 5.m4v - Video [Last Updated On: March 20th, 2012] [Originally Added On: March 20th, 2012]
- 017 The year of the dragon looks auspicious for Australian Biotechnology [Last Updated On: March 25th, 2012] [Originally Added On: March 25th, 2012]
- 018 Advanced Cell Technology and PharmAthene Poised to Benefit From Positive Legislation [Last Updated On: March 28th, 2012] [Originally Added On: March 28th, 2012]
- 019 Angel Biotechnology - Angel signs new contract with ReNeuron [Last Updated On: May 17th, 2012] [Originally Added On: May 17th, 2012]
- 020 Beike Earns AABB Accreditation for Cord Blood and Cord Tissue Banking [Last Updated On: May 29th, 2012] [Originally Added On: May 29th, 2012]
- 021 TaiGen Biotechnology Out-Licensed China Rights of Novel Antibiotic, Nemonoxacin, to Zhejiang Medicine [Last Updated On: June 25th, 2012] [Originally Added On: June 25th, 2012]
- 022 MYOS Names Veteran Biotechnology Executive Dr. Sol J. Barer to Chair Scientific Advisory Board [Last Updated On: June 27th, 2012] [Originally Added On: June 27th, 2012]
- 023 StemCells and Keryx Biopharmaceuticals Showing Strong Gains as Biotechnology Industry Soars in 2012 [Last Updated On: July 24th, 2012] [Originally Added On: July 24th, 2012]
- 024 Allele Biotechnology Announces New Advance in Production of Human Stem Cells [Last Updated On: September 15th, 2012] [Originally Added On: September 15th, 2012]
- 025 BIO Announces Therapeutic Workshops for 11th Annual BIO Investor Forum [Last Updated On: September 24th, 2012] [Originally Added On: September 24th, 2012]
- 026 Medistem and Superview Biotechnology Co. Ltd. Initiate Collaboration on Therapeutics Development Using Antibody and ... [Last Updated On: October 1st, 2012] [Originally Added On: October 1st, 2012]
- 027 Biotech Industry Applauds Introduction of the High Technology Small Business Research Incentives Act [Last Updated On: October 2nd, 2012] [Originally Added On: October 2nd, 2012]
- 028 Biotech Industry Look to Benefit From New Act Designed to Promote R&D Joint Ventures [Last Updated On: October 15th, 2012] [Originally Added On: October 15th, 2012]
- 029 David Lichtenstein: Biotechnology is Rich Area for Investment [Last Updated On: November 1st, 2012] [Originally Added On: November 1st, 2012]
- 030 26. Medical Biotechnology: Part Ic. Animal and Human Cloning and Genetic Engineering NQ - Video [Last Updated On: November 4th, 2012] [Originally Added On: November 4th, 2012]
- 031 Coare Biotechnology and ChemDiv Establish Co-Marketing and Service Collaboration [Last Updated On: November 8th, 2012] [Originally Added On: November 8th, 2012]
- 032 The Biotech Age: The Business Of Biotech And How To Profit From It - Richard Oliver - Video [Last Updated On: November 8th, 2012] [Originally Added On: November 8th, 2012]
- 033 blood banks | Umbilical Cord Blood Banking Could Be an Investment in Our Future Health - Video [Last Updated On: November 13th, 2012] [Originally Added On: November 13th, 2012]
- 034 Life Un(Ltd), Charis Thompson, Three Times a Woman- A Gendered Economy of Stem Cell Innovation Pt 1 - Video [Last Updated On: December 1st, 2012] [Originally Added On: December 1st, 2012]
- 035 Life UnLtd, Charis Thompson, Three Times a Woman A Gendered Economy of Stem Cell Innovation Pt 2 - Video [Last Updated On: December 1st, 2012] [Originally Added On: December 1st, 2012]
- 036 Biotechnology: Things you should know about Gene Therapy [Last Updated On: December 2nd, 2012] [Originally Added On: December 2nd, 2012]
- 037 Top trends for Biotechnology [Last Updated On: December 9th, 2012] [Originally Added On: December 9th, 2012]
- 038 What is exciting about Chemical Engineering? - Video [Last Updated On: December 20th, 2012] [Originally Added On: December 20th, 2012]
- 039 Things to know about the real fountain of youth [Last Updated On: January 20th, 2013] [Originally Added On: January 20th, 2013]
- 040 DNA testing is Good or Bad: Let’s Discuss [Last Updated On: March 10th, 2013] [Originally Added On: March 10th, 2013]
- 041 The Mystery about Cyanide Taste [Last Updated On: April 14th, 2013] [Originally Added On: April 14th, 2013]
- 042 Are Biodegradable Heart Stents Safe? [Last Updated On: April 21st, 2013] [Originally Added On: April 21st, 2013]
- 043 How good to use home pregnancy tests [Last Updated On: June 2nd, 2013] [Originally Added On: June 2nd, 2013]
- 044 Questions you should ask to doctor for Alzheimer disease [Last Updated On: July 7th, 2013] [Originally Added On: July 7th, 2013]
- 045 Matric Revision: Life Sciences: Genetics: Biotechnology (5/9): Cloning (1/4) - Video [Last Updated On: October 28th, 2013] [Originally Added On: October 28th, 2013]
- 046 Matric Revision: Life Sciences: Genetics: Biotechnology (6/9): Cloning (2/4) - Video [Last Updated On: October 28th, 2013] [Originally Added On: October 28th, 2013]
- 047 Adult Stem Cells Enhancer, From Fermented Biotechnology. - Video [Last Updated On: November 5th, 2013] [Originally Added On: November 5th, 2013]
- 048 Stem Cells Medical Applications of Biotechnology - Video [Last Updated On: January 30th, 2014] [Originally Added On: January 30th, 2014]
- 049 Biotechnology training for stem cell-related jobs265 - Video [Last Updated On: February 17th, 2014] [Originally Added On: February 17th, 2014]
- 050 Exciting business ideas in biotechnology and healthcare - Video [Last Updated On: February 18th, 2014] [Originally Added On: February 18th, 2014]
- 051 San Diego Hosts World's Largest Biotechnology Convention - Video [Last Updated On: June 25th, 2014] [Originally Added On: June 25th, 2014]
- 052 kineticvideo.com - Biotech 21st ethics-of-biotechnology-12540-4 - Video [Last Updated On: November 9th, 2014] [Originally Added On: November 9th, 2014]
- 053 HEMACORD Receives 2014 Prix Galien USA Best Biotechnology Product Award - Video [Last Updated On: December 8th, 2014] [Originally Added On: December 8th, 2014]
- 054 Omnigen S.A - Biotechnology - Video [Last Updated On: December 12th, 2014] [Originally Added On: December 12th, 2014]
- 055 DOXA: God of Wonders, Works...and Biotechnology - Video [Last Updated On: March 6th, 2015] [Originally Added On: March 6th, 2015]
- 056 BIOTECHNOLOGY ON EARTH - Video [Last Updated On: March 19th, 2015] [Originally Added On: March 19th, 2015]
- 057 Medzilla;Biotech Jobs, Pharmaceutical Jobs, Pharmaceutical ... [Last Updated On: May 19th, 2015] [Originally Added On: May 19th, 2015]
- 058 Biotechnology - Wikipedia, the free encyclopedia [Last Updated On: May 19th, 2015] [Originally Added On: May 19th, 2015]
- 059 Marx Biotechnology A disruptive technology that saves ... [Last Updated On: May 27th, 2015] [Originally Added On: May 27th, 2015]
- 060 What is Biotechnology ? - Access Excellence [Last Updated On: June 1st, 2015] [Originally Added On: June 1st, 2015]
- 061 Agricultural Biotechnology, Poverty Reduction, and Food ... [Last Updated On: June 2nd, 2015] [Originally Added On: June 2nd, 2015]
- 062 Biotechnology Industry Organization - Wikipedia, the free ... [Last Updated On: June 8th, 2015] [Originally Added On: June 8th, 2015]
- 063 biotechnology | Britannica.com [Last Updated On: June 10th, 2015] [Originally Added On: June 10th, 2015]
- 064 Biotechnology Salaries | Salary.com [Last Updated On: June 19th, 2015] [Originally Added On: June 19th, 2015]
- 065 Role of Bacteria in Environment - Biotechnology Forums [Last Updated On: June 26th, 2015] [Originally Added On: June 26th, 2015]
- 066 What is Biotechnology? | BIO [Last Updated On: July 2nd, 2015] [Originally Added On: July 2nd, 2015]
- 067 National Center for Biotechnology Information - Wikipedia ... [Last Updated On: July 3rd, 2015] [Originally Added On: July 3rd, 2015]
- 068 Top 10 biotech companies and Top 100 biotechnology places ... [Last Updated On: July 5th, 2015] [Originally Added On: July 5th, 2015]
- 069 Biotechnology Careers in India : How to become a ... [Last Updated On: July 13th, 2015] [Originally Added On: July 13th, 2015]
- 070 Biotechnology [Last Updated On: August 3rd, 2015] [Originally Added On: August 3rd, 2015]
- 071 Hemolysin - Wikipedia, the free encyclopedia [Last Updated On: August 4th, 2015] [Originally Added On: August 4th, 2015]
- 072 What is biotechnology? - Definition from WhatIs.com [Last Updated On: August 10th, 2015] [Originally Added On: August 10th, 2015]
- 073 Portal:Biotechnology - Wikipedia, the free encyclopedia [Last Updated On: August 11th, 2015] [Originally Added On: August 11th, 2015]
- 074 History of biotechnology - Wikipedia, the free encyclopedia [Last Updated On: August 17th, 2015] [Originally Added On: August 17th, 2015]
- 075 What is Biotechnology? [Last Updated On: September 4th, 2015] [Originally Added On: September 4th, 2015]
- 076 Biotechnology News -- ScienceDaily [Last Updated On: September 10th, 2015] [Originally Added On: September 10th, 2015]
- 077 Salt Lake Community College - Biotechnology [Last Updated On: October 11th, 2015] [Originally Added On: October 11th, 2015]
- 078 Biotechnology - Biomedical - Industrial Enzymes [Last Updated On: October 11th, 2015] [Originally Added On: October 11th, 2015]
- 079 Biotechnology - Center for Science in the Public Interest [Last Updated On: October 11th, 2015] [Originally Added On: October 11th, 2015]
- 080 Home - Biotechnology Programs [Last Updated On: October 11th, 2015] [Originally Added On: October 11th, 2015]